A systematic review of biomarkers to detect active tuberculosis
Top Cited Papers
- 25 February 2019
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Microbiology
- Vol. 4 (5), 748-758
- https://doi.org/10.1038/s41564-019-0380-2
Abstract
Millions of cases of tuberculosis (TB) go undiagnosed each year. Better diagnostic tools are urgently needed. Biomarker-based or multiple marker biosignature-based tests, ideally performed on blood or urine, for the detection of active TB might help to meet target product profiles proposed by the World Health Organization for point-of-care testing. We conducted a systematic review to summarize evidence on proposed biomarkers and biosignatures and evaluate their quality and level of evidence. We screened the titles and abstracts of 7,631 citations and included 443 publications that fulfilled the inclusion criteria and were published in 2010–2017. The types of biomarkers identified included antibodies, cytokines, metabolic activity markers, mycobacterial antigens and volatile organic compounds. Only 47% of studies reported a culture-based reference standard and diagnostic sensitivity and specificity. Forty-four biomarkers (4%) were identified in high-quality studies and met the target product profile minimum criteria, of which two have been incorporated into commercial assays. Of the 44 highest-quality biomarkers, 24 (55%) were multiple marker biosignatures. No meta-analyses were performed owing to between-study heterogeneity. In conclusion, TB biomarker discovery studies are often poorly designed and findings are rarely confirmed in independent studies. Few markers progress to a further developmental stage. More validation studies that consider the intended diagnostic use cases and apply rigorous design are needed. The extracted data from this review are currently being used by FIND as the foundation of a dynamic database in which biomarker data and developmental status will be presented.Keywords
This publication has 97 references indexed in Scilit:
- Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive studyThe Lancet Infectious Diseases, 2012
- Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2012
- Mycolic acids as diagnostic markers for tuberculosis case detection in humans and drug efficacy in miceEMBO Molecular Medicine, 2011
- Immunochromatographic IgG/IgM Test for Rapid Diagnosis of Active TuberculosisClinical and Vaccine Immunology, 2011
- Interferon-γ Release Assays for Active Pulmonary Tuberculosis Diagnosis in Adults in Low- and Middle-Income Countries: Systematic Review and Meta-analysisThe Journal of Infectious Diseases, 2011
- Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation studyThe Lancet, 2011
- Interferon-Gamma Release Assays for the Diagnosis of Latent Tuberculosis Infection in HIV-Infected Individuals: A Systematic Review and Meta-AnalysisJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- Assessment of Five Antigens from Mycobacterium tuberculosis for Serodiagnosis of TuberculosisClinical and Vaccine Immunology, 2011
- Breath biomarkers of active pulmonary tuberculosisTuberculosis, 2010
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001